Transcriptome Profiling of Neovascularized Corneas Reveals miR-204 as a Multi-target Biotherapy Deliverable by rAAVs
Corneal neovascularization (NV) is the major sight-threatening pathology caused by angiogenic stimuli. Current drugs that directly target pro-angiogenic factors to inhibit or reverse the disease require multiple rounds of administration and have limited efficacies. Here, we identify potential anti-a...
Main Authors: | Yi Lu, Phillip W.L. Tai, Jianzhong Ai, Dominic J. Gessler, Qin Su, Xieyi Yao, Qiang Zheng, Phillip D. Zamore, Xun Xu, Guangping Gao |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-03-01
|
Series: | Molecular Therapy: Nucleic Acids |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2162253117303207 |
Similar Items
-
Vectored Immunotherapeutics for Infectious Diseases: Can rAAVs Be The Game Changers for Fighting Transmissible Pathogens?
by: Wei Zhan, et al.
Published: (2021-05-01) -
rAAV8 and rAAV9-Mediated Long-Term Muscle Transduction with Tacrolimus (FK506) in Non-Human Primates
by: Akiko Ishii, et al.
Published: (2020-09-01) -
Immunomodulation in Administration of rAAV: Preclinical and Clinical Adjuvant Pharmacotherapies
by: Wing Sum Chu, et al.
Published: (2021-04-01) -
Optimization of miR-22 expression cassette for rAAV delivery on diabetes
by: Li Yang, et al.
Published: (2022-01-01) -
rAAV Manufacturing: The Challenges of Soft Sensing during Upstream Processing
by: Cristovão Freitas Iglesias, et al.
Published: (2023-02-01)